Shenyang Tonglian Group CO., Ltd
1 clinical trials · Sponsor
◉ Watch Shenyang Tonglian Group CO., Ltd
| Record | Firm | Date |
|---|---|---|
| Study to Evaluate Safety and Efficacy of Carrimycin for Treatment of Severe Coronavirus Disease 2019 (COVID-19) in Hospitalized Patients (NCT04672564) | Shenyang Tonglian Group CO., Ltd | 2021-03-30 |
Track Shenyang Tonglian Group CO., Ltd automatically
Every clearance here is in the API, with alerts when new ones post.